Stay updated on Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added 'Last verified' and 'Last known status was' fields to the record history and updated the revision label to 'Revision: v3.6.0' to reflect the latest data verification and versioning.
    Difference
    2%
    Check dated 2026-06-15T19:13:32.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The record history shows Revision: v3.5.5 replacing Revision: v3.5.4, indicating a new build/version of the ClinicalTrials.gov history interface.
    Difference
    0.1%
    Check dated 2026-06-08T16:27:21.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.5.4) to the Study Record Versions, replacing the previous v3.5.3. This updates the revision history for the study.
    Difference
    0.1%
    Check dated 2026-05-18T04:00:25.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov interface revision indicator has been updated from v3.5.0 to v3.5.3, reflecting a change to the site/versioning rather than the underlying trial history or study information.
    Difference
    0.1%
    Check dated 2026-04-26T15:23:12.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Record history adds v3.5.0 and removes v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T18:49:08.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the record history, and the previous revision v3.4.2 was removed from the visible list.
    Difference
    0.1%
    Check dated 2026-03-07T09:57:07.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.